Laboratory Operations At Diagnostic Sampling Tool Manufacturer Qiagen NV

Employees package Qiagen QIAxcel deoxyribonucleic acid (DNA) screening kits at the manufacturing facility of Qiagen NV in Hilden, Germany, on Friday, Aug. 22, 2014. Qiagen investors are betting the busiest year for health-care deals in more than a decade will lure acquirers to one of the industry's most expensive targets. Photographer: Jasper Juinen/Bloomberg via Getty Images
Employees package Qiagen QIAxcel deoxyribonucleic acid (DNA) screening kits at the manufacturing facility of Qiagen NV in Hilden, Germany, on Friday, Aug. 22, 2014. Qiagen investors are betting the busiest year for health-care deals in more than a decade will lure acquirers to one of the industry's most expensive targets. Photographer: Jasper Juinen/Bloomberg via Getty Images
Laboratory Operations At Diagnostic Sampling Tool Manufacturer Qiagen NV
EINE LIZENZ KAUFEN
Wie darf ich dieses Bild verwenden?
475,00 €
EUR

DETAILS

Einschränkungen:
Bei kommerzieller Verwendung sowie für verkaufsfördernde Zwecke kontaktieren Sie bitte Ihr lokales Büro.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Bildnachweis:
Bloomberg / Kontributor
Redaktionell #:
453958802
Kollektion:
Bloomberg
Erstellt am:
22. August 2014
Hochgeladen am:
Lizenztyp:
Lizenzpflichtig
Releaseangaben:
Kein Release verfügbar. Weitere Informationen
Quelle:
Bloomberg
Objektname:
GERMANY QIAGEN